- Last Close 5.60
- Sector Healthcare
- Industry Diagnostics & Research
- Investment Style Small Value
- Day Range 4.75 – 6.35
- Year Range 4.75 – 20.20
- Market Cap 7.7174 Mil
- Volume / Avg 169,477.0 / 11,190.2
- Price / Sales 0.60
- Price / Book 0.55
- Forward Div Yield —
- Trailing Div Yield —
Morningstar‘s Stock Analysis PRPO
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Company Profile PRPO
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings.
New Haven, CT, 06511
Our Quantitative Research team models direct competitors or comparable companies from a bottom-up perspective to find companies describing their business in a similar fashion.
|+$0.30 (5.58%)||−$0.05 (3.88%)||$0.00 (0.00%)||−$0.05 (2.94%)|
|7.72 Mil||60.16 Mil||8,119.79||55.57 Mil|
|Diagnostics & Research||Diagnostics & Research||Medical Devices||Diagnostics & Research|
* Trading data in this section is delayed by at least 15 minutes.
FAQs for Precipio Inc Stock
No. PRPO does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.
Learn more about dividend yield.
PRPO’s market cap is 7.72 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.
Learn more about market capitalization.
PRPO’s stock style is Small Value.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.
High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.
Learn more about style.
PRPO’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.
Compare PRPO’s historical performance against its industry peers and the overall market.